SRPT
Sarepta Therapeutics Inc. Healthcare - Biotechnology Investor Relations →
Sarepta Therapeutics Inc. (SRPT) closed at $18.50 as of 2026-02-02, trading 80.5% below its 200-week moving average of $95.05. This places SRPT in the extreme value zone. The stock is currently moving closer to the line, down from -78.7% last week. The 14-week RSI sits at 39, indicating neutral momentum.
Over the past 1448 weeks of data, SRPT has crossed below its 200-week moving average 22 times. On average, these episodes lasted 35 weeks. Historically, investors who bought SRPT at the start of these episodes saw an average one-year return of +34.2%.
With a market cap of $1939 million, SRPT is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -21.4%. The stock trades at 1.5x book value.
Share count has increased 11.2% over three years, indicating dilution.
Over the past 27.8 years, a hypothetical investment of $100 in SRPT would have grown to $44, compared to $1027 for the S&P 500. SRPT has returned -2.9% annualized vs 8.7% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: SRPT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SRPT Crosses Below the Line?
Across 22 historical episodes, buying SRPT when it crossed below its 200-week moving average produced an average return of +26.0% after 12 months (median -1.0%), compared to +8.7% for the S&P 500 over the same periods. 41% of those episodes were profitable after one year. After 24 months, the average return was +96.8% vs +14.8% for the index.
Each line shows $100 invested at the moment SRPT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SRPT has crossed below its 200-week MA 22 times with an average 1-year return of +34.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1998 | Nov 1999 | 77 | 57.7% | -38.6% | -53.0% |
| Dec 1999 | Dec 1999 | 1 | 4.4% | +33.3% | -39.1% |
| Jul 2000 | Jul 2000 | 1 | 4.0% | +39.7% | -51.9% |
| Oct 2000 | Apr 2001 | 30 | 40.7% | +17.1% | -51.2% |
| Apr 2002 | Apr 2002 | 1 | 0.5% | -47.4% | -55.8% |
| May 2002 | Jan 2006 | 191 | 71.8% | -5.6% | -47.4% |
| Jun 2006 | Aug 2006 | 10 | 33.2% | -23.1% | -20.7% |
| Sep 2006 | Oct 2006 | 5 | 7.1% | -24.0% | -12.9% |
| Nov 2006 | Jul 2010 | 191 | 83.3% | -35.1% | -14.1% |
| Mar 2011 | Apr 2011 | 1 | 4.0% | -0.6% | +98.9% |
| Jun 2011 | Jul 2011 | 4 | 13.3% | -48.9% | +128.4% |
| Jul 2011 | Mar 2012 | 33 | 60.4% | -4.1% | +109.8% |
| Apr 2012 | Jul 2012 | 16 | 55.4% | +497.5% | +205.3% |
| Nov 2013 | Nov 2013 | 2 | 10.0% | +6.7% | +28.7% |
| Oct 2014 | Oct 2014 | 1 | 3.9% | +97.6% | -1.4% |
| Oct 2014 | May 2015 | 29 | 39.4% | +48.8% | +14.4% |
| Jan 2016 | Aug 2016 | 32 | 51.8% | +164.9% | +29.6% |
| Jan 2021 | Aug 2022 | 83 | 43.9% | +3.9% | -77.5% |
| Oct 2022 | Nov 2022 | 2 | 3.2% | -24.7% | -82.1% |
| Jul 2023 | Aug 2023 | 3 | 1.9% | +37.5% | -82.5% |
| Oct 2023 | Jan 2024 | 11 | 27.7% | +22.8% | -82.7% |
| Feb 2025 | Ongoing | 51+ | 88.5% | Ongoing | -82.6% |
| Average | 35 | — | +34.2% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02